New Report Available: Caldera Health Limited - Product Pipeline Analysis, 2013 Update
Caldera Health Limited (Caldera) is a molecular in vitro diagnostics company. The company develops diagnostic devices for the detection of early stage prostate cancer. Its product technologies include proscanZ, guardianZ and auditor. Caldera's ProscaNZ is a blood test for prostate cancer which extends the diagnostic range of the current PSA test. The company's ProstScreen is a gene-based device to decide between indolent and rapidly progressive cancers and undertake treatment by use of urine samples, plasma, circulating and biopsy tissues. It...
View full press release